# PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
Canonical URL: https://biopharmsignal.com/news/PMCB/pharmacyte-biotech-inc-announces-closing-of-7-million-financing
Ticker: PMCB
Company: PharmaCyte Biotech
Source: PharmaCyte Biotech
Published: 2025-08-20 13:15 EST
Original Source URL: https://ir.pharmacyte.com
## Article Body
No article body is available yet.
## Recent Company News
- 2025-11-25 14:15 EST — [PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment](https://biopharmsignal.com/news/PMCB/pharmacyte-biotech-successfully-monetizes-femasys-stake-strengthening-cash-position-and-underscoring-strategic-capital-deployment) — Source: PharmaCyte Biotech
- 2025-09-02 13:20 EST — [PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications](https://biopharmsignal.com/news/PMCB/pharmacyte-biotech-inc-increases-stake-in-tnf-pharmaceuticals-around-recent-license-for-breakthrough-light-speed-computing-platform-for-use-in-cryptocurrency-applications) — Source: PharmaCyte Biotech
- 2025-08-20 13:15 EST — [PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing](https://biopharmsignal.com/news/PMCB/pharmacyte-biotech-inc-announces-closing-of-7-million-financing) — Source: PharmaCyte Biotech
- 2025-08-18 13:15 EST — [PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors](https://biopharmsignal.com/news/PMCB/pharmacyte-biotech-inc-announces-7-million-capital-raise-led-by-existing-investors) — Source: PharmaCyte Biotech
- 2024-05-21 13:00 EST — [PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease](https://biopharmsignal.com/news/PMCB/pharmacyte-biotech-makes-7-million-strategic-investment-in-mymd-a-biopharmaceutical-company-focused-on-inflammatory-disease) — Source: PharmaCyte Biotech
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)